Gefapixant is a selective P2X3 receptor antagonist that is being investigated for the treatment of chronic cough. It works by blocking the action of the P2X3 receptor, which plays a role in the sensory pathways of cough reflex. The drug has shown promise in clinical trials for reducing cough frequency and severity.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Gefapixant and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Gefapixant impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Gefapixant-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
